Jochen Haag

4.7k total citations
66 papers, 3.7k citations indexed

About

Jochen Haag is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, Jochen Haag has authored 66 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 21 papers in Rheumatology and 20 papers in Oncology. Recurrent topics in Jochen Haag's work include Osteoarthritis Treatment and Mechanisms (20 papers), TGF-β signaling in diseases (8 papers) and Cancer-related Molecular Pathways (7 papers). Jochen Haag is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (20 papers), TGF-β signaling in diseases (8 papers) and Cancer-related Molecular Pathways (7 papers). Jochen Haag collaborates with scholars based in Germany, United States and Netherlands. Jochen Haag's co-authors include Thomas Aigner, M.N. Gould, Pia Margarethe Gebhard, Christoph Röcken, Eckart Bartnik, Mary J. Lindstrom, Christina Kendziorski, Rafael A. Irizarry, Brigitte Bau and Sandra Krüger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Oncogene.

In The Last Decade

Jochen Haag

66 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jochen Haag Germany 33 1.4k 1.2k 931 730 565 66 3.7k
Guangbin Luo United States 35 4.6k 3.2× 576 0.5× 1.5k 1.6× 1.2k 1.6× 304 0.5× 85 7.3k
Yukihiko Saeki Japan 34 1.7k 1.2× 1.4k 1.2× 847 0.9× 285 0.4× 267 0.5× 114 4.3k
Elaine F. Remmers United States 49 2.5k 1.7× 2.3k 2.0× 1.3k 1.4× 693 0.9× 456 0.8× 136 7.3k
Takuya Sato Japan 43 3.2k 2.2× 517 0.4× 1.1k 1.2× 714 1.0× 521 0.9× 111 5.7k
Dagmar Scheel‐Toellner United Kingdom 35 1.9k 1.3× 930 0.8× 1.0k 1.1× 382 0.5× 307 0.5× 63 5.4k
Mahmoud R. Hussein Egypt 35 1.2k 0.8× 283 0.2× 978 1.1× 466 0.6× 394 0.7× 146 4.1k
Vily Panoutsakopoulou Greece 16 3.3k 2.3× 975 0.8× 702 0.8× 395 0.5× 266 0.5× 27 5.3k
Zongbing You United States 35 1.7k 1.2× 287 0.2× 1.5k 1.6× 607 0.8× 446 0.8× 87 4.3k
Haibo Zhao United States 39 2.9k 2.0× 346 0.3× 1.3k 1.4× 654 0.9× 219 0.4× 94 4.4k
Dimitris L. Kontoyiannis Greece 33 3.0k 2.0× 715 0.6× 1.0k 1.1× 1.2k 1.7× 313 0.6× 52 5.7k

Countries citing papers authored by Jochen Haag

Since Specialization
Citations

This map shows the geographic impact of Jochen Haag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Haag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Haag more than expected).

Fields of papers citing papers by Jochen Haag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen Haag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Haag. The network helps show where Jochen Haag may publish in the future.

Co-authorship network of co-authors of Jochen Haag

This figure shows the co-authorship network connecting the top 25 collaborators of Jochen Haag. A scholar is included among the top collaborators of Jochen Haag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jochen Haag. Jochen Haag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Behrens, Hans‐Michael, et al.. (2023). MDM2 amplification is rare in gastric cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(6). 795–807. 1 indexed citations
2.
Janßen, Ottmar, Fabian Schütt, Rainer Adelung, et al.. (2023). Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells. International Journal of Molecular Sciences. 24(10). 9075–9075. 1 indexed citations
3.
Richter, Julia, et al.. (2023). CD27 / CD70 pathway activation in primary cutaneous CD4 + small/medium T‐cell lymphoproliferative disorder. The Journal of Pathology. 262(2). 189–197. 1 indexed citations
4.
Esser, Daniela, Jochen Haag, Stefan Schreiber, et al.. (2017). Interpreting whole genome and exome sequencing data of individual gastric cancer samples. BMC Genomics. 18(1). 517–517. 11 indexed citations
5.
Egberts, Friederike, Ann‐Sophie Bohne, Sandra Krüger, et al.. (2015). Varying Mutational Alterations in Multiple Primary Melanomas. Journal of Molecular Diagnostics. 18(1). 75–83. 13 indexed citations
6.
Heppner, Barbara Ingold, Katharina Balschun, Jochen Haag, et al.. (2014). HER2/neu testing in primary colorectal carcinoma. British Journal of Cancer. 111(10). 1977–1984. 127 indexed citations
7.
Quabius, Elgar Susanne, Jochen Haag, Anna Sophie Hoffmann, et al.. (2014). Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany. International Journal of Oncology. 46(1). 414–422. 37 indexed citations
8.
Urbán, Péter, et al.. (2012). ATTR amyloid in the carpal tunnel ligament is frequently of wildtype transthyretin origin. Amyloid. 20(1). 1–6. 32 indexed citations
9.
Balschun, Katharina, et al.. (2011). KRAS, NRAS, PIK3CA Exon 20, and BRAF Genotypes in Synchronous and Metachronous Primary Colorectal Cancers. Journal of Molecular Diagnostics. 13(4). 436–445. 38 indexed citations
10.
Aigner, Thomas, Stefan Söder, Pia Margarethe Gebhard, Audrey McAlinden, & Jochen Haag. (2007). Mechanisms of Disease: role of chondrocytes in the pathogenesis of osteoarthritis—structure, chaos and senescence. Nature Clinical Practice Rheumatology. 3(7). 391–399. 212 indexed citations
11.
Mueller, Susanna, et al.. (2007). Senile EBV‐associated B‐cell lymphoproliferative disorder of prepatellar bursa in an elderly patient with multifocal urate arthropathy. Hematological Oncology. 25(3). 140–142. 2 indexed citations
12.
Aigner, Thomas, Jochen Haag, & Ralf Zimmer. (2007). Functional genomics, evo-devo and systems biology: a chance to overcome complexity?. Current Opinion in Rheumatology. 19(5). 463–470. 6 indexed citations
13.
Wetzel, Petra, Jochen Haag, Valentina Câmpean, et al.. (2006). Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominently localized to the distal nephron. Kidney International. 70(4). 717–723. 31 indexed citations
14.
Cotroneo, Michelle S., Jochen Haag, Peti Thuwajit, et al.. (2006). Characterizing a rat Brca2 knockout model. Oncogene. 26(11). 1626–1635. 25 indexed citations
15.
Haag, Jochen, Susan Chubinskaya, & Thomas Aigner. (2006). Hgs physically interacts with Smad5 and attenuates BMP signaling. Experimental Cell Research. 312(7). 1153–1163. 6 indexed citations
16.
Aigner, Thomas, Stephan Soeder, & Jochen Haag. (2006). IL-1ß and BMPs - Interactive players of cartilage matrix degradation and regeneration. European Cells and Materials. 12. 49–56. 89 indexed citations
17.
19.
Kendziorski, Christina, et al.. (2005). On the utility of pooling biological samples in microarray experiments. Proceedings of the National Academy of Sciences. 102(12). 4252–4257. 413 indexed citations
20.
Haag, Jochen. (1998). The molecular phylogeny of trypanosomes: evidence for an early divergence of the Salivaria. Molecular and Biochemical Parasitology. 91(1). 37–49. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026